Antenatal Magnesium Sulfate Improves Preterm Outcomes

Administering antenatal magnesium sulfate prior to early delivery significantly improves neonatal survival without cerebral palsy. Consequently, clinicians widely use this intervention in routine obstetric care for fetal neuroprotection. Recent real-world data from binational registries confirms these remarkable clinical benefits in very preterm infants.

Real-World Impact of Antenatal Magnesium Sulfate

Large population-based registry studies demonstrate clear clinical advantages. Specifically, exposure to antenatal magnesium sulfate reduces the combined outcome of death or moderate-to-severe functional disability. Therefore, obstetricians should routinely identify eligible patients who face imminent preterm birth.

Clinical Recommendations for Fetal Neuroprotection

Healthcare providers should administer an intravenous loading dose when delivery is anticipated before thirty weeks of gestation. Furthermore, clinical protocols recommend continuous monitoring to maintain maternal safety during infusion. However, urgent delivery for acute maternal or fetal indications must never suffer delay.

Frequently Asked Questions

Q1: What is the primary benefit of giving antenatal magnesium sulfate before preterm delivery?

It significantly lowers the risk of cerebral palsy and increases survival without severe functional impairment in premature neonates.

Q2: When should clinicians administer magnesium sulfate for neuroprotection?

Clinicians typically administer it to women facing imminent preterm birth, ideally commencing four hours prior to delivery.

References

1. Shepherd E et al. Antenatal magnesium sulfate prior to very preterm birth in routine care is associated with increased survival without cerebral palsy. Am J Obstet Gynecol. 2026 Jul 30. doi: undefined. PMID: 42532419.
2. Rouse DJ, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359(9):895-905.
3. Crowther CA, et al. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis. PLoS Med. 2017;14(10):e1002398.